Wellington Management Group
XLRN

Wellington Management Group’s Acceleron Pharma XLRN Stock Holding History

Wellington Management Group’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-715,322
Closed -$123M – 2375
2021
Q3 		$123M Sell
715,322
-1,010,633
-59% -$132M 0.02% 564
2021
Q2 		$217M Buy
1,725,955
+233,101
+16% +$29.4M 0.04% 424
2021
Q1 		$202M Buy
1,492,854
+280,611
+23% +$36.2M 0.04% 424
2020
Q4 		$155M Sell
1,212,243
-361,168
-23% -$42.3M 0.03% 478
2020
Q3 		$177M Buy
1,573,411
+39,500
+3% +$3.93M 0.04% 397
2020
Q2 		$146M Sell
1,533,911
-395,655
-21% -$38.1M 0.03% 432
2020
Q1 		$173M Sell
1,929,566
-509,103
-21% -$39.6M 0.05% 334
2019
Q4 		$129M Buy
2,438,669
+934,619
+62% +$42.6M 0.03% 505
2019
Q3 		$59.4M Buy
1,504,050
+25,736
+2% +$1.12M 0.01% 680
2019
Q2 		$60.7M Buy
1,478,314
+10,035
+0.7% +$415K 0.01% 703
2019
Q1 		$68.4M Buy
+1,468,279
New +$64.5M 0.02% 649
2014
Q1 		– Sell
-56,450
Closed -$2.23M – 2260
2013
Q4 		$2.23M Buy
+56,450
New +$1.36M ﹤0.01% 1670

Wellington Management Group's XLRN Position: Q4 2021 in Review

Wellington Management Group sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 715,322 shares — an estimated $123M sold.

Wellington Management Group first reported a position in XLRN in Q4 2013 and held it in 12 quarters. The position peaked at $217M in Q2 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Wellington Management Group reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Wellington Management Group sold 715,322 Acceleron Pharma shares in Q4 2021, an estimated $123M.
  • Wellington Management Group first reported a position in Acceleron Pharma in Q4 2013 and held it in 12 quarters.
  • Wellington Management Group's Acceleron Pharma position peaked at $217M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Wellington Management Group's 13F filing for Q4 2021, filed 11 Feb 2022.